Literature DB >> 33407732

Chinese nutraceuticals and physical activity; their role in neurodegenerative tauopathies.

Abdullahi Alausa1, Sunday Ogundepo1, Barakat Olaleke1, Rofiat Adeyemi2, Mercy Olatinwo1, Aminat Ismail3.   

Abstract

The onset of neurodegenerative disease has not only been a major cause of scientific worry, but of economic burden to the health system. This condition has been further attributed to mis-stability, deletion or mutation of tau protein, causing the onset of Corticobasal degeneration, Pick's diseases, Progressive supranuclear palsy, Argyrophilic grains disease, Alzheimer's diseases etc. as scientifically renowned. This is mainly related to dysregulation of translational machinery, upregulation of proinflammatory cytokines and inhibition of several essential cascades such as ERK signaling cascade, GSK3β, CREB, and PKA/PKB (Akt) signaling cascades that enhances protein processing, normal protein folding, cognitive function, and microtubule associated tau stability. Administration of some nutrients and/or bioactive compounds has a high tendency to impede tau mediated inflammation at neuronal level. Furthermore, prevention and neutralization of protein misfolding through modulation of microtubule tau stability and prevention of protein misfolding is by virtue few of the numerous beneficial effects of physical activity. Of utmost important in this study is the exploration of promising bioactivities of nutraceuticals found in china and the ameliorating potential of physical activity on tauopathies, while highlighting animal and in vitro studies that have been investigated for comprehensive understanding of its potential and an insight into the effects on human highly probable to tau mediated neurodegeneration.

Entities:  

Keywords:  Bioactive compounds; Neurodegenerative diseases; Nutraceutical; Physical activity; Tau

Year:  2021        PMID: 33407732     DOI: 10.1186/s13020-020-00418-7

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


  217 in total

Review 1.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 2.  Exercise Regulation of Cognitive Function and Neuroplasticity in the Healthy and Diseased Brain.

Authors:  Gilian F Hamilton; Justin S Rhodes
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-05       Impact factor: 3.622

3.  A protein factor essential for microtubule assembly.

Authors:  M D Weingarten; A H Lockwood; S Y Hwo; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

Review 4.  A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.

Authors:  Miranda E Orr; A Campbell Sullivan; Bess Frost
Journal:  Trends Pharmacol Sci       Date:  2017-04-25       Impact factor: 14.819

5.  Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function.

Authors:  Q Ding; S Vaynman; M Akhavan; Z Ying; F Gomez-Pinilla
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

Review 6.  Exercise and brain neurotransmission.

Authors:  R Meeusen; K De Meirleir
Journal:  Sports Med       Date:  1995-09       Impact factor: 11.136

7.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

8.  First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.

Authors:  Damian M Cummings; Wenfei Liu; Erik Portelius; Sevinç Bayram; Marina Yasvoina; Sui-Hin Ho; Hélène Smits; Shabinah S Ali; Rivka Steinberg; Chrysia-Maria Pegasiou; Owain T James; Mar Matarin; Jill C Richardson; Henrik Zetterberg; Kaj Blennow; John A Hardy; Dervis A Salih; Frances A Edwards
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

9.  Tau phosphorylation affects its axonal transport and degradation.

Authors:  Teresa Rodríguez-Martín; Inmaculada Cuchillo-Ibáñez; Wendy Noble; Fanon Nyenya; Brian H Anderton; Diane P Hanger
Journal:  Neurobiol Aging       Date:  2013-04-17       Impact factor: 4.673

Review 10.  Tau protein modifications and interactions: their role in function and dysfunction.

Authors:  Anna Mietelska-Porowska; Urszula Wasik; Marcelina Goras; Anna Filipek; Grazyna Niewiadomska
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

View more
  1 in total

1.  α-Glyceryl-phosphoryl-ethanolamine protects human hippocampal neurons from ageing-induced cellular alterations.

Authors:  Elisa Zappelli; Simona Daniele; Lorenzo Ceccarelli; Matteo Vergassola; Lorella Ragni; Giorgina Mangano; Claudia Martini
Journal:  Eur J Neurosci       Date:  2022-08-12       Impact factor: 3.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.